Biotechnology - Cell Therapeutics, North America


Popular Filters

US FDA puts partial clinical hold on Cell Thera's blood cancer drug tosedostat trial


US biotech firm Cell Therapeutics (Nasdaq: CTIC) revealed this week in a filing with the Securities Exchange…

BiotechnologyCell TherapeuticsNorth AmericaOncologyRegulationResearchtosedostat

Cell Therapeutics updates on Pixuvri


Seattle, USA-based Cell Therapeutics (Nasdaq and MTA: CTIC) says that it has voluntarily withdrawn its…

BiotechnologyCell TherapeuticsNorth AmericaOncologyPixuvriRegulation

Back to top